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Edited by John DenuMitochondrial ATP synthase is a reversible nanomotor
synthesizing or hydrolyzing ATP depending on the potential
across the membrane in which it is embedded. In the unicel-
lular parasite Trypanosoma brucei, the direction of the com-
plex depends on the life cycle stage of this digenetic parasite: in
the midgut of the tsetse fly vector (procyclic form), the FoF1–
ATP synthase generates ATP by oxidative phosphorylation,
whereas in the mammalian bloodstream form, this complex
hydrolyzes ATP and maintains mitochondrial membrane po-
tential (ΔΨm). The trypanosome FoF1–ATP synthase contains
numerous lineage-specific subunits whose roles remain un-
known. Here, we seek to elucidate the function of the lineage-
specific protein Tb1, the largest membrane-bound subunit. In
procyclic form cells, Tb1 silencing resulted in a decrease of
FoF1–ATP synthase monomers and dimers, rerouting of
mitochondrial electron transfer to the alternative oxidase,
reduced growth rate and cellular ATP levels, and elevated ΔΨm
and total cellular reactive oxygen species levels. In bloodstream
form parasites, RNAi silencing of Tb1 by 90% resulted in
decreased FoF1–ATPase monomers and dimers, but it had no
apparent effect on growth. The same findings were obtained by
silencing of the oligomycin sensitivity-conferring protein, a
conserved subunit in T. brucei FoF1–ATP synthase. However,
as expected, nearly complete Tb1 or oligomycin sensitivity-
conferring protein suppression was lethal because of the
inability to sustain ΔΨm. The diminishment of FoF1–ATPase
complexes was further accompanied by a decreased ADP/ATP
ratio and reduced oxygen consumption via the alternative ox-
idase. Our data illuminate the often diametrically opposed
bioenergetic consequences of FoF1–ATP synthase loss in insect
versus mammalian forms of the parasite.
The FoF1–ATP synthase is a multisubunit protein complex
capable of coupling ATP synthesis/hydrolysis with trans-
membrane proton translocation. In eukaryotes, this nanoma-
chine is embedded in the inner mitochondrial membrane andThis article contains supporting information.
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BY license (http://creativecommons.org/licenses/by/4.0/).consists of two parts, the matrix-facing F1 and the membrane-
embedded Fo. The F1 domain, known as F1-ATPase, is
responsible for the phosphorylation of ADP to ATP, and it
consists of a heterohexamer of α and β subunits and a central
stalk (subunits γ, δ, and ε) that connects the (αβ)3-headpiece to
the Fo section. The core of the Fo section consists of a ring of c
subunits that tightly interacts with subunit a, a highly hydro-
phobic subunit encoded by the mitochondrial genome in most
eukaryotes, including trypanosomatids (1, 2). Aside from the
central stalk, the interaction between the Fo and F1 domains is
mediated by the peripheral stalk, an elongated structure that
immobilizes the (αβ)3-headpiece during the rotation of the
central rotor shaft (central stalk plus c-ring) by directly binding
to subunits α and β (1). Despite the long period of evolutionary
divergence of more than 2 billion years, the structure of pro-
karyotic and eukaryotic FoF1–ATP synthases is notably
conserved, mainly at the level of tertiary and quaternary
structures (2).
Nevertheless, in recent years, purifications and high-
resolution structures of FoF1–ATP synthases from nonclas-
sical model organisms revealed a wider variety in complex
composition and structural organization than initially recog-
nized (3–7). This includes the Trypanosoma brucei brucei
FoF1–ATP synthase, an enzyme composed of 23 subunits, of
which 14 are either lineage specific or highly divergent (8). For
example, the lineage-specific subunits p18 and ATPaseTb2
(Tb2 in short) elaborate the otherwise conserved F1 domain
(9, 10) and represent one of the largest peripheral stalk sub-
units found in FoF1–ATP synthases to date (11), respectively.
The peculiarities of T. brucei FoF1–ATP synthase are not
restricted only to complex composition. A remarkable feature
of this complex is that its activity depends on the parasite’s life
cycle. The procyclic form (PCF), also known as insect midgut
stage, harbors a conventional mitochondrion where the
FoF1–ATP synthase produces ATP (forward mode) using the
electrochemical gradient across the inner mitochondrial
membrane generated by the proton-pumping activity of res-
piratory complexes III and IV (8, 12, 13). In contrast, the in-
fectious stage of the mammalian host, termed long slender
bloodstream form (BSF), lacks a cytochrome-mediated elec-
tron transport chain and respires exclusively via the alternativeJ. Biol. Chem. (2021) 296 100357 1
Biochemistry and Molecular Biology. This is an open access article under the CC
Trypanosoma brucei FoF1–ATP synthaseoxidase (AOX) pathway (14). The mitochondrial membrane
potential (ΔΨm) is generated by the proton-pumping activity
(reverse mode) of the FoF1–ATP synthase (aka FoF1–ATPase)
complex at the expense of ATP (15, 16). Hence, T. brucei
represents a unique eukaryotic system that allows to study
both modes of the FoF1–ATP synthase in physiological settings
and the distinct bioenergetic consequences upon the loss of
either of the activities.
The reverse mode of the FoF1–ATP synthase complex is
used by some prokaryotes (17), but it is unusual in eukaryotes,
where it occurs under rare nonphysiological and stress con-
ditions, such as hypoxia or anoxia. In these cases, the respi-
ratory arrest and subsequent collapse of the ΔΨm causes a
reversal of the FoF1–ATP synthase to generate a modest ΔΨm
(18, 19). The reversal of FoF1–ATP synthase also takes place in
cells lacking mitochondrial DNA, which maintain ΔΨm by an
electrogenic exchange of ATP4− for ADP3− by the ADP/ATP
carrier (AAC) coupled to ATP hydrolysis by an incomplete
FoF1–ATPase (20–22). The depletion of ATP due to the hy-
drolytic activity of the FoF1–ATP synthase during ischemic
conditions is mitigated by a unidirectional inhibitor, the
inhibitory factor 1 (23). Noteworthy, in T. brucei, the expres-
sion of inhibitory factor 1 is tightly regulated throughout the
parasite’s life cycle, and its experimental expression in BSF
trypanosomes results in cell death (24, 25), highlighting the
indispensability of the FoF1–ATPase complex for BSF
T. brucei.
ATPaseTb1 (Tb1 in short; systematic TriTrypDB.org ID
Tb927.10.520) (47 kDa) is one of the 14 lineage-specific sub-
units and the largest Fo subunit of the T. brucei FoF1–ATP
synthase complex (8) (named Tb7760 in that study, after its
previous systematic TriTrypDB ID TB10.70.7760). Down-
regulation of Tb1 in PCF trypanosomes inhibits cell growth,
destabilizes FoF1–ATP synthase, and affects both the ATP
synthetic and hydrolytic activities of the complex (8). Here, we
studied in more detail the mitochondrial phenotypes associ-
ated with the downregulation of Tb1 in PCF cells and further
explore the role of this subunit, as well as that of the peripheral
subunit oligomycin sensitivity-conferring protein (OSCP), in
the BSF stage.
Results
Tb1 is a membrane-bound subunit of the Fo moiety
Tb1, the largest membrane-associated subunit of the
T. brucei FoF1–ATP synthase, has homologs in representatives
of the Euglenozoa group but appears to be absent from other
eukaryotic lineages (8). In agreement with the reduced size and
activity of the mitochondrion in the BSFs of T. brucei (26), Tb1
is less abundant in BSF cells than in PCF cells and barely
detectable in the mitochondrial DNA-lacking (aka akineto-
plastic) strains T. b. brucei Dk 164 and Trypanosoma brucei
evansi AnTat 3/3 (Fig. 1A). To confirm the submitochondrial
localization of Tb1 and determine how it is associated with the
inner mitochondrial membrane, we performed carbonate
extraction of mitochondria purified from T. brucei cells
expressing C-terminally v5-tagged Tb1 (Fig. 1B). Tb1 is found2 J. Biol. Chem. (2021) 296 100357exclusively in the membrane fraction, and the marker proteins,
enolase, mitochondrial RNA-binding protein 1, and AAC, are
detected in their expected compartments: cytosol, mitochon-
drial matrix, and mitochondrial membrane, respectively. This
result suggests that Tb1 is an integral membrane protein. In
PCF and BSF cells, Tb1 is present in fully assembled FoF1–ATP
synthase monomers and dimers, as documented by high-
resolution clear native electrophoresis (Fig. 1C) and sedi-
mentation in glycerol gradient (Fig. 1D) followed by Western
blot analyses with a specific anti-Tb1 antibody. In glycerol
gradients, the Tb1 antibody detected, in addition to Tb1
migrating with the FoF1–ATP synthase, nonspecific bands of
40 kDa and 42 kDa in PCF and of 55 kDa in BSF, which are
identified by the asterisk (Fig. 1D).
Our observations that Tb1 is present in fully assembled
FoF1–ATP synthase are in agreement with a recent cryogenic
electron microscopy structure of the FoF1–ATP synthase
dimer from Euglena gracilis, a closely related free-living spe-
cies within the Euglenozoa group, in which Tb1 is found on
the matrix side of the membrane part of the complex at the
peripheral stalk base (6). We predicted the structure of
T. brucei Tb1 using E. gracilis Tb1 as a template (Fig. 1E). The
modeling showed that both Tb1 orthologs share a fold similar
to the mitochondrial distribution and morphology protein 38
(Mdm38) from Saccharomyces cerevisiae, a protein suggested
to be involved in the assembly of the mitochondrial-encoded
subunit a into the Fo moiety (27). Although several algo-
rithms predicted one transmembrane helix in Tb1, the protein
does not span the inner mitochondrial membrane. Instead, the
presumptive transmembrane region occurs as a HTH motif
intruding into the membrane (Fig. 1E), and therefore, Tb1 is a
monotopic membrane protein.
Silencing of Tb1 in PCF cells leads to a transient increase of
ΔΨm followed by redirection of respiration toward AOX
Previously, we showed that Tb1 silencing in PCF cells leads
to decreased steady-state levels of fully assembled FoF1–ATP
synthase complexes, and, therefore, to less ATP produced by
substrate-stimulated oxidative phosphorylation in digitonin-
permeabilized cells (8). Here, we explored in more detail the
effect of Tb1 silencing on mitochondrial physiology and bio-
energetics of PCF cells. As expected, Tb1 silencing caused a
progressive growth phenotype detected first at day 4 of RNAi
induction (Fig. 2A). Western blot analysis using a specific anti-
Tb1 antibody showed that Tb1 protein expression was reduced
to less than 10% at day 2 of RNAi induction (Fig. 2B). The
downregulation of Tb1 was accompanied by a decrease in the
steady-state level of the peripheral stalk subunit Tb2, whereas
the abundance of the F1 moiety subunit β was not as strongly
affected (Fig. 2B). The structural integrity and the activity of
the FoF1–ATP synthase complex were assessed by blue native
electrophoresis (BNE) followed by Western blotting and in-gel
activity staining of the complex, respectively (Fig. 2C). Western
blot analyses of native complexes showed a significant reduc-
tion of FoF1–ATP synthase monomers and dimers at days 2
and 4 of RNAi induction. In agreement with the steady-state
Figure 1. Tb1 is a membrane-bound FoF1–ATP synthase subunit. A, Western blot analysis of whole-cell lysates prepared from 1 × 10
7 T. brucei PCF, BSF,
Dk 164, and Trypanosoma brucei evansi AnTat 3/3 cells probed with anti-Tb1 antibody. The laboratory-induced Dk 164 and the naturally occurring
laboratory-adapted T. b. evansi AnTat 3/3 are BSF strains devoid of mitochondrial DNA. An asterisk points to a nonspecific band detected by the anti-Tb1
antibody. B, Western blot analysis of subcellular fractions obtained by carbonate extraction of mitochondria purified from PCF cells expressing v5-tagged
Tb1 protein. Blots were probed with anti-v5 antibody, anti-enolase, anti-AAC, and anti-MRP1 antibodies to visualize Tb1, cytosolic enolase, inner mito-
chondrial membrane-bound AAC, and mitochondrial matrix–localized MRP1, respectively. C, High-resolution clear native electrophoresis of crude mito-
chondrial vesicles from PCF and BSF parasites. The F1-ATPase (F1) and the monomeric (M) and dimeric (D) forms of the complex were visualized using
specific antibodies against subunits p18 and Tb1. D, glycerol gradient sedimentation of PCF and BSF lysed mitochondrial samples to determine the
sedimentation profile of F1– and FoF1–ATP synthase complexes. Glycerol gradient fractions were analyzed by SDS-PAGE followed by Western blotting using
antibodies against p18 and Tb1. The p18 antibody depicts the sedimentation profile of both F1–ATPase and the monomeric/dimeric states of the complex,
whereas the Tb1 antibody detects only the monomeric/dimeric assemblies of the FoF1–ATP synthase. Asterisks represent nonspecific bands detected by the
anti-Tb1 antibody. E, the structure of Tb1 from Euglena determined by cryo-EM (PDB ID 6TDU (6), light yellow) and the predicted structure of T. brucei Tb1. In
the E. gracilis Tb1, the region absent in T. brucei is shown in orange. In the T. brucei Tb1, the Mdm38-like fold and the helix-turn-helix motif (HTH) intruding
into the membrane are shown in light blue and dark blue, respectively. In the space-filling model of the E. gracilis FoF1–ATP synthase, the F1–ATPase and the
c-ring are blue, the peripheral stalk subunits are pink, and all other membrane subunits are gray. AAC, ADP/ATP carrier; BSF, bloodstream form; cryo-EM,
cryogenic electron microscopy; Cyt, cytosol; Matr, mitochondrial matrix; Mdm38, mitochondrial distribution and morphology protein 38; Mem, mito-
chondrial membranes; Mito, mitochondria; MRP1, mitochondrial RNA binding protein 1; PCF, procyclic form; Tb1, ATPaseTb1.
Trypanosoma brucei FoF1–ATP synthaselevels of subunit β, the free F1-ATPase moiety was assembled
and active, and it accumulated in Tb1-silenced cells. The
decreased levels of fully assembled FoF1–ATP synthase com-
plexes affected ATP production by oxidative phosphorylation
(8), which was reflected by a 25% reduction in the total
cellular ATP levels (Fig. 2D) and by a 50% increase in the ADP/
ATP ratio (Fig. 2E) by day 4 of RNAi induction. Suppression of
Tb1 expression also caused a mild, but statistically significant,
increase in ΔΨm at day 2 of RNAi induction (Fig. 2F), but
notably, this increase was only transient. In PCF cells, the
ΔΨm is maintained by the activity of respiratory complexes III
and IV, passing electrons from ubiquinol to molecular oxygen.
However, electrons can be rerouted to another electron
acceptor, a plant-like AOX, which reduces molecular oxygen
to water without proton translocation (28). By doing so, PCF
cells can uncouple cellular respiration from ΔΨm generation.
To test if the cells responded to the hyperpolarization detected
at day 2 by rewiring the electrons toward AOX, we measured
the oxygen consumption rate in the presence of potassiumcyanide (KCN) and salicylhydroxamic acid (SHAM), inhibitors
of complex IV and AOX, respectively. Indeed, we detected that
the respiration of Tb1-silenced cells is more sensitive to
SHAM compared with KCN, confirming the higher proportion
of AOX-mediated respiration (Fig. 2G). This rerouting of
electrons was accompanied by an increase in AOX expression
as determined by Western blot (Fig. 2B). Because complex III
is one of the major producers of harmful superoxide (O2
,−)
molecules, an important subclass of reactive oxygen species
(ROS) (29), we measured the mitochondrial concentration of
O2
,− before and after Tb1 RNAi in PCF cells (Fig. 2H). We
found that O2
,− decreased over time after Tb1 ablation, sup-
porting the proposed rerouting of electrons from complexes
III and IV toward AOX, perhaps as a protective mechanism
against oxidative stress (30–32). Despite the lower levels of
mitochondrial O2
,−, the disruption of fully assembled FoF1–
ATP synthase induced changes in cellular physiology that ul-
timately led to higher levels of various cytosolic
ROS molecules (e.g., peroxyl, hydroxyl) as measured byJ. Biol. Chem. (2021) 296 100357 3
Figure 2. Loss of Tb1 in PCF cells affects the structural integrity of the FoF1–ATP synthase complex and induces changes in mitochondrial
physiology. A, growth of noninduced (−tet) and Tb1 RNAi–induced (+tet) PCF cells measured for 8 days. Cumulative cell density was calculated from the
cell counts adjusted by the dilution factor needed to seed the cultures at 2 × 106 cells/ml each day. B, Western blot analysis of PCF Tb1 RNAi trypanosomes
grown in the absence (−tet) or presence (+tet) of tetracycline for 2 and 4 days. Whole-cell lysates were subjected to SDS-PAGE followed by immunostaining
with antibodies against Tb1 and Tb2 (Fo moiety), subunit β (F1 moiety), and AOX. The numbers beneath each blot represent the abundance of immu-
nodetected protein expressed as a percentage of the noninduced sample after normalizing to the signal intensity of the mitochondrial HSP70 probing
(loading control). C, BNE of 4 μg of DDM-lysed mitochondria from PCF Tb1 RNAi–noninduced (−tet) and PCF Tb1 RNAi–induced (+tet, 2 and 4 days) cells
followed by Western blot analysis using antibodies against subunit β and Tb2 to detect free F1 and monomeric (M) and dimeric (D) ATP synthase complexes
(first two panels). BNE of 60 μg of DDM-lysed mitochondria from PCF Tb1 RNAi–noninduced (−tet) and PCF Tb1 RNAi–induced (+tet, 2 and 4 days) cells
followed by in-gel staining of ATPase activity (rightmost panel). D, total cellular ATP levels of PCF Tb1 RNAi–noninduced cells (−tet) and cells induced for 2
and 4 days (+tet, 2 days and 4 days) (means ± SD, n = 4, Student’s unpaired t-test). E, relative ADP/ATP ratio of PCF Tb1 RNAi–noninduced cells (−tet) and
cells induced for 2 and 4 days (+tet, 2 days and 4 days) (means ± SD, n = 4, Student’s unpaired t-test). F, flow cytometry analysis of TMRE-stained PCF Tb1
RNAi–noninduced cells (−tet) and cells induced for 2, 4, and 6 days (+tet, 2 days, 4 days, and 6 days) to measure ΔΨm. The addition of FCCP served as a
control for mitochondrial membrane depolarization (+FCCP) (means ± SD, n = 6, Student’s unpaired t-test). G, the oxygen consumption rate of PCF Tb1 RNAi
live cells in the presence of glycerol-3-phosphate. After the addition of the substrate, cells were consuming oxygen at the steady rate. Injection of SHAM
inhibited AOX-mediated respiration. The difference between the original values and the values after addition of SHAM is graphed as AOX-mediated
respiration. Additional injection of KCN inhibited complex IV–mediated respiration and ceased the oxygen consumption of the cells. The difference be-
tween the values after SHAM addition and after KCN addition is graphed as complex IV–mediated respiration (means ± SD, n = 6, Student’s unpaired t-test).
H and I, flow cytometry analysis of MitoSOX-treated (H) and H2DCFHDA-treated (I) PCF Tb1 RNAi–noninduced cells (−tet) and cells induced for 2, 4, and
6 days (+tet, 2 days, 4 days, and 6 days) to measure mitochondrial O2
,− and total cellular ROS levels, respectively (means ± SD, n = 6, Student’s unpaired
t-test). ΔΨm, mitochondrial membrane potential; AOX, alternative oxidase; BNE, blue native electrophoresis; DDM, dodecylmaltoside; FCCP, carbonyl cy-
anide 4-(trifluoromethoxy) phenylhydrazone; H2DCFHDA, dichlorodihydrofluorescein; KCN, potassium cyanide; O2
,−, superoxide; PCF, procyclic form; ROS,
reactive oxygen species; SHAM, salicylhydroxamic acid; Tb1, ATPaseTb1; Tb2, ATPaseTb2; TMRE, tetramethylrhodamine ethyl ester.
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Trypanosoma brucei FoF1–ATP synthasedichlorodihydrofluorescein (H2DCFHDA), a fluorescent ROS-
sensitive dye (Fig. 2I). This gradual increment of oxidative
stress might have contributed to the growth phenotype
observed in parasites with suppressed Tb1 expression.
Stringent Tb1 silencing leads to a virtually complete loss of
FoF1–ATPase complex in BSF parasites and mitochondrial
membrane depolarization, followed by cell death
In contrast to the canonical role of the FoF1–ATP synthase
in PCF cells, BSF cells use the reverse activity of this complex,
which generates ΔΨm at the expense of ATP (15, 16). We
silenced Tb1 in BSF cells by using an RNAi construct targeting
the 3’ region of the Tb1 ORF. This caused a decrease of Tb1 to
11% at day 2 of RNAi induction, reaching undetectable levels
of the protein at day 3 (Fig. 3A). As expected, the BSF Tb1 3’
RNAi cell line exhibited a strong growth phenotype and ceased
growing entirely by day 4 of induction (Fig. 3B). The steady-
state levels of F1–ATPase subunits β and p18 were decreased
by 40% at day 2, whereas the steady-state levels of the
Fo-associated subunits Tb2 and OSCP dropped to 10%
(Fig. 3C). Moreover, the levels of AAC were decreased by 60%
(Fig. 3C), suggesting that disruption of the FoF1–ATPase might
affect the stability of this transporter. As in PCF cells, Tb1
downregulation caused a strong decrease of FoF1–ATPase
monomers and dimers while there was a simultaneous increase
in free F1 subcomplex (Fig. 3D, Fig. S1A).
Similarly, a conditional double knock-out (cDKO) of OSCP
resulted in undetectable levels of OSCP at day 2 (Fig. 3E),
which was accompanied by a strong growth phenotype
(Fig. 3F). In this cell line, termed BSF OSCP cDKO, both OSCP
alleles were replaced by drug resistance cassettes, and an
ectopic copy of the OSCP gene, whose expression depends on
the presence of tetracycline in the culture medium, was
introduced (Fig. S2). The removal of tetracycline led to abla-
tion of OSCP expression, reduced levels of F1 subunits to
80%, and Fo subunits to 10% (Fig. 3G), as well as virtually
complete loss of the monomeric and dimeric forms of the
complex (Fig. 3H, Fig. S1B), by day 2 of tetracycline removal.
To investigate the effect of the FoF1–ATPase loss on ΔΨm,
we used flow cytometry analysis of intact, live cells stained with
tetramethylrhodamine ethyl ester (TMRE). In both BSF Tb1 3’
RNAi and OSCP cDKO cell lines, the ΔΨm was strongly
compromised at day 2 of RNAi induction and tetracycline
removal, respectively (Fig. 4, A and B), preceding the observed
growth defect. To corroborate these results, we determined the
ability of the mitochondrion to generate ΔΨm in digitonin-
permeabilized cells using safranin O dye. Control BSF Tb1 3’
RNAi and OSCP cDKO cells were able to build up and retain a
ΔΨm, as addition of ATP caused a decrease in safranin O
fluorescence, indicating stacking of the dye within the ener-
gized organelle. This decrease was completely reversed by
adding either oligomycin (Fig. 4, C and D, black lines) or
carboxyatractyloside (Fig. S3, A and D, black lines), inhibitors
of the FoF1–ATP synthase and the AAC, respectively. Subse-
quent addition of the uncoupler SF 6847 had no further effect
on depolarization. In contrast, cells silenced for Tb1 or ablatedfor OSCP were unable to generate ΔΨm in situ (Fig. 4, C and
D, red lines). No changes in fluorescence were detected when
the addition of oligomycin or carboxyatractyloside preceded
that of ATP (Fig. S3, B, C, E and F), confirming that the
decrease in safranin O fluorescence observed in control cells
indeed depends on the ATP-hydrolyzing activity of the FoF1–
ATPase and on the ADP/ATP exchanging activity of the AAC.
In summary, these measurements indicate that, in the absence
of either Tb1 or OSCP, BSF cells cannot generate ΔΨm, pre-
sumably because the proton-pumping FoF1–ATPase is
completely disrupted in these cells.
Because the activity of the F1–ATPase is tightly connected
to the cellular ADP/ATP pool (33), we measured the cellular
ADP/ATP ratio in control BSF Tb1 3’ RNAi and OSCP cDKO
cells and in cells with diminished Tb1 and OSCP expression.
The ADP/ATP ratio was already significantly decreased at day
1 (Fig. 4, E and F), the opposite of the effect observed in PCF
cells (compare Fig. 2E), likely because of the dysfunctional
FoF1–ATPase. Higher levels of ATP than ADP may also affect
the glycolytic flux, which is directly linked to respiration via
the mitochondrial glycerol-3-phosphate dehydrogenase (34)
and/or activity of AOX (35). Indeed, decreased levels of FoF1–
ATPase caused lower glycerol-3-phosphate–stimulated oxy-
gen consumption in digitonin-permeabilized BSF cells
depleted of Tb1 or OSCP (Fig. 4, G and H). As expected, in
both samples, the measured respiration was fully inhibited by
addition of SHAM.
Suppression of Fo subunits expression to 10% is compatible
with BSF cell viability in vitro
The virtually complete ablation of either Tb1 or OSCP
(Fig. 3, A and E) is lethal for BSF trypanosomes, and this is in
agreement with previous studies examining FoF1–ATPase
subunits (9, 11, 16). Surprisingly, these parasites can with-
stand a 90 to 95% loss of the same proteins as revealed by
analysis of two different cell lines: a BSF Tb1 5’ RNAi cell
line, in which the dsRNA targets the 5’ region of the Tb1
ORF, and a BSF OSCP RNAi cell line. In these cell lines, Tb1
and OSCP expressions were stably downregulated to 7 to 9%
and 3 to 4%, respectively, over the period of 7 days of RNAi
induction (Fig. 5, A and B), with no obvious effect on their
growth rate (Fig. 5, C and D). The different outcomes in the
viability of the BSF Tb1 RNAi cell lines might be attributed to
different efficiencies of the 3’ and 5’ targeted RNAi probes or
to their distinctive genetic backgrounds (Tb1 3’ RNAi:
EATRO 1125 AnTat 1.1 versus Tb1 5’ RNAi: BSF Lister 427).
However, as the same difference in viability was observed for
BSF OSCP cDKO and OSCP RNAi cells, which share the
same genetic background, the distinct phenotypes were most
likely due to the differences in stringency of suppression.
Thus, we decided to further investigate the basis for the
observed differences.
Western blot analyses revealed a correlative decrease in Fo
subunits in both BSF Tb1 5’ and OSCP RNAi cell lines,
whereas F1 subunits stayed largely unaffected. Similar to BSF
Tb1 3’ RNAi cells, the expression of AOX was slightlyJ. Biol. Chem. (2021) 296 100357 5
Figure 3. Virtually complete loss of FoF1–ATPase is lethal to BSF cells. A, Western blot of whole-cell lysates from BSF Tb1 3’ RNAi–noninduced (−tet) and
BSF Tb1 3’ RNAi–induced (+tet, 1–3 days) cells using an antibody against Tb1. The numbers beneath the blot represent the abundance of immunodetected
Tb1 expressed as a percentage of the noninduced samples after normalizing to the signal intensity of the enolase probing (loading control). An asterisk
points to a nonspecific band detected by anti-Tb1 antibody. B, growth of BSF Tb1 3’ RNAi–noninduced (−tet) and BSF Tb1 3’ RNAi–induced (+tet) cells
measured for 4 days. Cumulative cell density was calculated from the cell counts adjusted by the dilution factor needed to seed the cultures at 2 × 105 cells/
ml each day. C, Western blot analysis of whole-cell lysates from BSF Tb1 3’ RNAi–noninduced (−tet) and cells induced for 1 and 2 days (+tet) using an-
tibodies against the F1 moiety (anti-β and anti-p18), the Fo moiety (anti-Tb2 and anti-OSCP), and inner mitochondrial membrane proteins (anti-AAC and
anti-AOX). The immunoblot probed with anti-mitochondrial HSP70 antibody served as loading control. The densitometric analysis is depicted by the
percentages beneath each blot and was carried out as in Figure 2B. D, BNE of 20 μg of DDM-lysed mitochondria from BSF Tb1 3’ RNAi–noninduced cells
(−tet) and cells induced for 1 and 2 days (+tet) followed by Western blot analysis using antibodies to detect free F1 (anti-subunit β) and monomeric (M) and
dimeric (D) FoF1–ATPase complexes (anti-Tb2). E, Western blot of whole-cell lysates from BSF OSCP cDKO cells grown in the presence (+tet) or absence (−tet)
of tetracycline for 1 and 2 days using an antibody against OSCP. The numbers beneath the blot represent the abundance of immunodetected OSCP
expressed as a percentage of the +tet sample after normalizing to the signal intensity of the enolase probing (loading control). F, the growth curve of BSF
OSCP cDKO cells cultured in the presence (+tet) or absence (−tet) of tetracycline for 4 days. Cumulative cell density was calculated as in Figure 3B. G,
Western blot analysis of whole-cell lysates from BSF OSCP cDKO cells cultured in the presence (+tet) or absence (−tet) of tetracycline for 1 day and 2 days
using antibodies against the F1 moiety (anti-β and anti-p18), the Fo moiety (anti-Tb1 and anti-Tb2) and inner mitochondrial membrane proteins (anti-AAC
and anti-AOX). The immunoblot probed with antimitochondrial HSP70 antibody served as the loading control. The densitometric analysis is depicted by the
percentages beneath each blot and was carried out as in Figure 2B. The asterisk points to a nonspecific band detected by anti-Tb1 antibody. H, BNE of 20 μg
of DDM-lysed mitochondria from BSF OSCP cDKO cells grown in the presence (+tet) or absence (−tet) of tetracycline for 1 day and 2 days followed by
Western blot analysis using antibodies to detect free F1 (anti-subunit β) and monomeric (M) and dimeric (D) FoF1–ATPase complexes (anti-Tb2). AAC, ADP/
ATP carrier; AOX, alternative oxidase; BNE, blue native electrophoresis; BSF, bloodstream form; cDKO, conditional double knock-out; DDM, dode-
cylmaltoside; OSCP, oligomycin sensitivity-conferring protein; Tb1, ATPaseTb1; Tb2, ATPaseTb2.
Trypanosoma brucei FoF1–ATP synthaseupregulated, whereas the levels of AAC were halved (Fig. 5, E
and F). Next, we analyzed the assembly of FoF1–ATPase
complexes in BSF Tb1 5’ and OSCP RNAi cells by BNE.
Silencing of Tb1 and OSCP induced monomer and dimer6 J. Biol. Chem. (2021) 296 100357instability as F1–ATPase subcomplexes accumulated in RNAi-
induced cells, and less monomeric and dimeric forms were
detected using antibodies against F1 and Fo moieties (Fig. 5, G
and H, Fig. S1, C and D), but compared with BSF Tb1 3’
Figure 4. Virtually complete loss of FoF1–ATPase leads to a sudden collapse of ΔΨm, lower ADP/ATP ratio, and reduced respiration rate in BSF
parasites. A, flow cytometry analysis of TMRE-stained BSF Tb1 3’ RNAi–noninduced cells (−tet) and cells induced for 1 day and 2 days (+tet, 1 day and 2
days) to detect changes in the ΔΨm. The addition of FCCP served as a control for mitochondrial membrane depolarization (+FCCP) (means ± SD, n = 4,
Student’s unpaired t-test). B, flow cytometry analysis of TMRE-stained BSF OSCP cDKO cells grown in the presence (+tet) or absence of tetracycline for 1 day
and 2 days (−tet, 1 day and 2 days) to detect changes in the ΔΨm. The addition of FCCP served as a control for mitochondrial membrane depolarization
(+FCCP) (means ± SD, n = 4, Student’s unpaired t-test). C, mitochondrial membrane polarization detected using safranin O dye in digitonin-permeabilized
BSF Tb1 3’ RNAi–noninduced cells (−tet, black line) and cells induced for 2 days (+tet, 2 days, red line) in the presence of ATP. ATP, oligomycin (OLM),
carboxyatractyloside (cATR), and SF 6847, an uncoupler, were added where indicated. cATR was added after OLM to test for any further depolarization of
the mitochondrial membrane due to inhibition of the AAC, whose electrogenic activity can potentially contribute in the generation of ATP-stimulated ΔΨm.
D, mitochondrial membrane polarization detected using safranin O dye in digitonin-permeabilized BSF OSCP cDKO cells grown in the presence (+tet, black
line) or absence of tetracycline for 2 days (−tet, 2 days, red line) after the addition of ATP. ATP, oligomycin (OLM), carboxyatractyloside (cATR), and SF 6847,
an uncoupler, were added where indicated. cATR was added after OLM to test for any further depolarization of the mitochondrial membrane due to
inhibition of the AAC, whose electrogenic activity can potentially contribute in the generation of ATP-stimulated ΔΨm. E, relative ADP/ATP ratio in BSF Tb1
3’ RNAi–noninduced cells (−tet) and cells induced for 1 day and 2 days (+tet, 1 day and 2 days) (means ± SD, n = 6, Student’s unpaired t-test). F, relative
ADP/ATP ratio in BSF OSCP cDKO cells cultured in the presence (+tet) or absence of tetracycline for 1 day and 2 days (−tet, 1 day and 2 days) (means ± SD,
n = 6, Student’s unpaired t-test). G, oxygen consumption rates of digitonin-permeabilized BSF Tb1 3’ RNAi–noninduced cells (−tet, black line) and cells
induced for 2 days (+tet, 2 days, red line) in the presence of glycerol-3-phosphate. Respiration was arrested by the addition of SHAM where indicated. H,
oxygen consumption rates of digitonin-permeabilized BSF OSCP cDKO cells grown in the presence (+tet, black line) or absence of tetracycline for 2 days
(−tet, 2 days, red line) after addition of glycerol-3-phosphate. Respiration was arrested by addition of SHAM where indicated. ΔΨm, mitochondrial mem-
brane potential; AAC, ADP/ATP carrier; BSF, bloodstream form; cDKO, conditional double knock-out; FCCP, carbonyl cyanide 4-(trifluoromethoxy) phe-
nylhydrazone; OSCP, oligomycin sensitivity-conferring protein; SHAM, salicylhydroxamic acid; TMRE, tetramethylrhodamine ethyl ester.
Trypanosoma brucei FoF1–ATP synthaseRNAi–induced cells and OSCP cDKO cells (Fig. 3, D and H),
the decrease was not as profound.
We hypothesized that the observed differences in the
viability of the examined cell lines may lay in the varying
amounts of remaining active FoF1–ATPase complexes.
Therefore, we quantified and compared the changes in the
steady-state levels of F1 (β and p18) and Fo (Tb1, Tb2 and
OSCP) subunits for the four BSF cell lines. At day 4 of RNAi
induction, when the steady-state levels of the target proteins in
BSF Tb1 5’ and OSCP RNAi cells were the lowest in their
respective cell lines (Fig. 5, A and B), the steady-state levels of
the tested Fo subunits remained significantly higher (25.1% ±
12.3%, means ± SD) than those in BSF Tb1 3’ RNAi and OSCP
cDKO cells by day 2 of RNAi induction or tetracyclineremoval, respectively (9.2% ± 4.2%, means ± SD) (Fig. 5I). We
propose that in the BSF Tb1 3’ RNAi and the OSCP cDKO cell
lines, the levels of Fo subunits drop under a threshold that does
not allow the parasite to assemble a sufficient amount of FoF1–
ATPase complexes to maintain its viability. Assuming a direct
relationship between the steady-state levels of individual Fo
subunits and the total levels of FoF1 holocomplex, it would
suggest that at least a 10% of assembled FoF1–ATPase com-
plexes is necessary to maintain the viability of BSF T. brucei
cells in vitro.
To test if the detected decrease in the levels of FoF1–ATPase
monomers and dimers in BSF Tb1 5’ and OSCP RNAi cells
affects ΔΨm, we measured TMRE fluorescence in live
cells from both cell lines by flow cytometry. We did not detectJ. Biol. Chem. (2021) 296 100357 7
Figure 5. BSF cells are able to tolerate suppression of Tb1 and OSCP expression by 90 to 95%. A and B, Western blot analysis of whole-cell lysates from
BSF Tb1 5’ RNAi (A) and BSF OSCP RNAi (B) noninduced cells (−tet) and cells induced for 1 to 7 days (+tet) using antibodies against Tb1 and OSCP,
respectively. The numbers beneath the blot represent the abundance of immunodetected Tb1 (A) or OSCP (B) expressed as a percentage of the noninduced
sample after normalizing to the signal intensity of the enolase probing (loading control). In Figure 5A, an asterisk points to a nonspecific band detected by
anti-Tb1 antibody. C and D, growth of BSF Tb1 5’ RNAi (C) and BSF OSCP RNAi (D) noninduced (−tet) and induced (+tet) cells measured for 7 days. Cu-
mulative cell density was calculated as in Figure 3B. E and F, Western blot analysis of whole-cell lysates from BSF Tb1 5’ RNAi (E) and BSF OSCP RNAi (F)
noninduced cells (−tet) and cells induced for 2 and 4 days (+tet) using antibodies against the F1 moiety (anti-β and anti-p18), the Fo moiety (anti-Tb1, anti-
Tb2, and anti-OSCP), and inner mitochondrial membrane proteins (anti-AAC and anti-AOX). The immunoblots probed with anti-mitochondrial HSP70
antibody served as the loading control. The densitometric analysis is depicted by the percentages beneath each blot and was carried out as in Figure 2B.
The asterisk points to a nonspecific band detected by anti-Tb1 antibody. G and H, BNE of 20 μg of DDM-lysed mitochondria from BSF Tb1 5’ RNAi (G) and
BSF OSCP RNAi (H) noninduced cells (−tet) and cells induced for 2 and 4 days (+tet) followed by Western blot analysis using antibodies to detect free F1
(anti-subunit β) and monomeric (M) and dimeric (D) FoF1–ATPase complexes (anti-Tb2). I, comparison of changes in F1 and Fo subunit levels between BSF
Tb1 3’ RNAi (red circles)/BSF OSCP cDKO cells (red triangles) and BSF Tb1 5’ RNAi (blue circles)/BSF OSCP RNAi (blue triangles) cells along the days of RNAi
induction/tetracycline removal. The antibody signals of F1 (β and p18) and Fo (Tb1, Tb2, and OSCP) subunits at days 1 and 2 of RNAi induction/tetracycline
removal (BSF Tb1 3’ RNAi and OSCP cDKO cells, respectively) and at days 2 and 4 of RNAi induction (BSF Tb1 5’ and OSCP RNAi cells) were quantified and
normalized as in Figure 2B. In both Tb1 RNAi cell lines, the plotted values of Fo subunits correspond to the quantified signals of anti-Tb2 and anti-OSCP
antibodies. In the OSCP cDKO and OSCP RNAi cell lines, the plotted values of Fo subunits correspond to the quantified signals of anti-Tb1 and anti-Tb2
antibodies. The values were analyzed statistically using GraphPad Prism 8.0 software (means ± SD, n ≥ 4, Student’s unpaired t-test). ΔΨm, mitochon-
drial membrane potential; AAC, ADP/ATP carrier; AOX, alternative oxidase; BSF, bloodstream form; cDKO, conditional double knock-out; ns, not significant;
OSCP, oligomycin sensitivity-conferring protein; Tb1, ATPaseTb1.
Trypanosoma brucei FoF1–ATP synthaseany differences in ΔΨm between the measured time
points (Fig. 6A). Furthermore, we assessed the ability of the
FoF1–ATPase to polarize the mitochondrial membrane in8 J. Biol. Chem. (2021) 296 100357digitonin-permeabilized BSF Tb1 5’ and OSCP RNAi cells
using safranin O dye in the presence of ATP. Albeit reduced,
compared with control cells (Fig. 6, B and C, Fig. S4, A and D,
Figure 6. BSF cells with 90 to 95% reduced expression of Tb1 and OSCP have unchanged ΔΨm but are more sensitive to AAC and FoF1–ATPase
inhibitors. A, flow cytometry analysis of TMRE-stained BSF Tb1 5’ RNAi (brick-red circles) and BSF OSCP RNAi (orange triangles) noninduced cells (−tet) and
cells induced for 2 and 4 days (+tet, 2 days and 4 days) to detect changes in ΔΨm. The addition of FCCP served as a control for mitochondrial membrane
depolarization (means ± SD, n = 4, Student’s unpaired t-test). B and C, mitochondrial membrane polarization detected using safranin O dye in digitonin-
permeabilized BSF Tb1 5’ RNAi (B) and BSF OSCP RNAi (C) noninduced cells (−tet, black lines) and cells induced for 4 days (+tet, 4 days, red lines) in the
presence of ATP. ATP, oligomycin (OLM), carboxyatractyloside (cATR), and SF 6847, an uncoupler, were added where indicated. cATR was added after OLM
to test for any further depolarization of the mitochondrial membrane due to inhibition of the AAC, whose electrogenic activity can potentially contribute in
the generation of ATP-stimulated ΔΨm. D and E, sensitivity of BSF Tb1 5’ RNAi– and BSF OSCP RNAi–noninduced cells (−tet, brick-red and orange full lines,
respectively) and cells induced for 4 days (+tet, 4 days, brick-red and orange dashed lines, respectively) to carboxyatractyloside (cATR) (D) and to oligomycin
(OLM) (E) estimated by resazurin cell-viability assay. The dose–response curves were calculated using GraphPad Prism 8.0 software. The calculated IC50
values are shown beside the corresponding sample and are expressed in mM and in μg/ml for cATR and OLM, respectively. ΔΨm, mitochondrial membrane
potential; AAC, ADP/ATP carrier; BSF, bloodstream form; FCCP, carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone; OSCP, oligomycin sensitivity-
conferring protein; TMRE, tetramethylrhodamine ethyl ester.
Trypanosoma brucei FoF1–ATP synthaseblack lines), RNAi-induced cells from both cell lines were
still able to generate a ΔΨm (Fig. 6, B and C, Fig. S4, A and D,
red lines). In all four cases, the inner mitochondrial
membrane was fully depolarized by the addition of oligomycin
(Fig. 6, B and C) or carboxyatractyloside (Fig. S4, A and D).
The results were further validated by measuring safranin O
fluorescence when either oligomycin or carboxyatractyloside
was present before ATP addition (Fig. S4, B, C, E and F). These
observations show that the FoF1–ATPase activity is affected in
BSF Tb1 5’ and OSCP RNAi–induced cells but is not fully
abolished as observed for BSF Tb1 3’ RNAi and OSCP cDKO
cells (Fig. 4, C and D, Fig. S3, A and D, red lines).The difference between the ΔΨm measured in vivo (by flow
cytometry) and in situ (by safranin O) may reflect the
different aspects of ΔΨm generation interrogated by these
assays: the former measures the actual magnitude of ΔΨm in
living cells, and the latter, the capacity of cells to generate
ΔΨm. The differences observed imply that BSF cells do not
use FoF1–ATPase complexes at full capacity to generate
ΔΨm, and therefore, a significant decrease in these assem-
blies has no effect on their total ΔΨm and the viability of cells
grown in culture. The need for the 10% of remaining FoF1–
ATPase complexes (Fig. 5I) in the mitochondria is corrobo-
rated by increased sensitivity of BSF Tb1 5’ and OSCPJ. Biol. Chem. (2021) 296 100357 9
Trypanosoma brucei FoF1–ATP synthaseRNAi–induced cells to carboxyatractyloside (12 and 73
times, respectively) and to oligomycin (2.5 and 2.1 times,
respectively) as measured by resazurin cell viability assay
(Fig. 6, D and E).
In summary, our data provide insight into the distinct bio-
energetic consequences of the loss of FoF1–ATP synthase/
ATPase in PCF and BSF parasites. We showed that a decrease
in the FoF1–ATP synthase levels in PCF cells led to lowered
ATP levels and transiently increased ΔΨm, which manifested
in the form of oxidative stress and slower cell growth. In BSF
trypanosomes, as reported before, a full disruption of the
FoF1–ATPase caused the loss of ΔΨm followed by cell death,
but we observed that these parasites can withstand a sub-
stantial loss of the complex without an obvious effect on
viability in culture.Discussion
Tb1 is the largest membrane-associated subunit of the
FoF1–ATP synthase in T. brucei. Inferring from the FoF1–ATP
synthase structure of the related organism E. gracilis, Tb1 is
located on the matrix side of the Fo periphery (6) and contains
an Mdm38-like fold. Mdm38 is a component of the yeast
mitochondrial cotranslational membrane insertion machinery,
and it has been reported to assist in the assembly of the
mitochondrial-encoded proton channel subunit a into the
FoF1–ATP synthase (27). Despite the structural similarity be-
tween Mdm38 and Tb1, the former was never copurified with
either electron transport chain complexes or FoF1–ATP syn-
thase (27, 36, 37), whereas the latter is a bona fide component
of the euglenozoan FoF1–ATP synthase (6, 8, 38). In addition,
the E. gracilis Tb1 ortholog contacts nearly exclusively a
species-specific extension of subunit a (6), suggesting that it is
not involved in the incorporation of subunit a into the com-
plex in the same way as in yeast. Based on the predicted
structural conservancy of Tb1 and compositional similarity of
the FoF1–ATP synthase in T. brucei and Euglena, it is
reasonable to assume that Tb1 in T. brucei is located on the
periphery of the dimer. Presumably, it establishes very few, or
none at all, contacts with subunits involved directly in the
proton translocation or dimerization of the complex. Yet, Tb1
is absolutely crucial for the FoF1–ATP synthase integrity (8),
potentially by aiding in the stability or assembly of auxiliary Fo
subunits.
Here, we silenced Tb1 subunit by RNAi with high efficiency
in two cultivable forms of T. brucei to study phenotypes
associated with FoF1–ATP synthase loss. In PCF cells, the se-
vere loss of the monomeric and dimeric forms of the
FoF1–ATP synthase after depletion of Tb1 causes a transient
hyperpolarization of the inner mitochondrial membrane. This
effect is then reversed by redirecting electrons from the con-
ventional respiratory chain complexes III and IV toward AOX,
as documented by the increased SHAM-sensitive respiration.
The increased respiration through the AOX pathway is
accompanied by a gradual but mild reduction in the ΔΨm
(25% by day 6 of RNAi induction), consistent with the fact
that AOX is incapable of pumping protons across the inner10 J. Biol. Chem. (2021) 296 100357mitochondrial membrane, and therefore, does not contribute
to the generation of ΔΨm (28). Moreover, the increase in
AOX-mediated respiration led to lowered levels of mito-
chondrial O2
,−, presumably produced to a large extent by
complex III. The rerouting of electrons toward AOX is a
phenomenon that was already reported in PCF T. brucei cells
when complexes III and IV were downregulated (39, 40) and
may reflect a protective mechanism also used by plants to cope
with the increase in ROS generation associated with inhibition
of the cytochrome pathway (39). Similarly, artificial expression
of AOX in fruit fly and mouse cells was shown to limit
mitochondrial ROS formation when respiration was inhibited
by antimycin (inhibitor of complex III) or cyanide (inhibitor of
complex IV) (31, 32).
Furthermore, we observed that the total cellular ATP levels
decreased only by 25% at day 4 of RNAi induction, reflecting
the ability of PCF cells to rely also on ATP production through
both cytosolic and mitochondrial substrate-level phosphory-
lation via the pyruvate kinase and the succinyl-CoA synthe-
tase, respectively, when grown in glucose-rich conditions (41,
42). Although the ATP levels were reduced just 25%, there
was a 50% increase in the ADP/ATP ratio. This could be
explained by the avid ATP consumption by the accumulated
F1 subcomplexes, as reflected by the in-gel staining of ATPase
activity. An increased ADP/ATP ratio could also reflect a
higher intracellular ATP demand, namely by processes inten-
ded to restore homeostasis. Although the increased respiration
through AOX contributed to the reduction of intra-
mitochondrial O2
,− levels, prolonged inhibition of the oxida-
tive phosphorylation pathway due to Tb1 downregulation led
to an increase of various cytosolic ROS, causing oxidative
stress. Because the synthesis of certain ROS-detoxifying mol-
ecules requires ATP (43), we hypothesize that the inability of
PCF Tb1 RNAi–induced cells to cope with the increasing
concentrations of cytosolic ROS might be due to the lowered
levels of intracellular ATP caused by inhibition of oxidative
phosphorylation.
In BSF T. brucei, the FoF1–ATP synthase complex operates
in reverse mode to generate the vital ΔΨm (15, 16). Therefore,
the cell death that followed the collapse of the ΔΨm in para-
sites fully depleted of Tb1 or OSCP was expected and is
consistent with the earlier studies. Nevertheless, while Tb1 and
OSCP suppression down to 3 to 10% caused a corresponding
loss of FoF1–ATPase complexes, these BSF trypanosomes were
able to thrive in culture without any obvious effect on their
viability. Similarly, perturbation of mitochondrial translation
in BSF cells, manifested by decreased levels of FoF1–ATPase
due to reduced production of its mitochondrial encoded
subunit a, had no effect on growth in culture (44). Moreover,
the ΔΨm of BSF Tb1 5’ and OSCP RNAi–induced cells was
not affected when measured by flow cytometry of live cells, but
there was a significant reduction in the ability of the FoF1–
ATPase to generate a proton gradient when estimated in
permeabilized cells by safranin O assay. This phenomenon can
be explained by a combination of two factors: the higher
sensitivity of safranin O to changes in ΔΨm compared with
TMRE (45) and a possible overcapacity of the FoF1–ATPase
Trypanosoma brucei FoF1–ATP synthasecomplex in BSF trypanosomes. The overcapacity of certain
enzymes has already been documented in T. brucei. For
instance, the reduction of the maximum rate (Vmax) of AOX
reaction by 50% was predicted to have no effect on oxygen
consumption (46). Taken together, our observations would
suggest that although the FoF1–ATPase is a promising drug
target, the potential drug would have to inhibit the majority of
the assembled complexes to exert cytotoxic effects, although
the proportion of FoF1–ATPase complexes that is required to
sustain the viability of the parasite in the host environment
might be different compared with the situation in vitro.
Dyskinetoplastic trypanosomes are BSF cells that partially or
entirely lack their mitochondrial DNA, termed kinetoplast
DNA, and consequently, the mitochondrial-encoded subunit a
(47–49). Because the vestigial F-ATPase in dyskinetoplastic
cells is incapable of proton pumping, it is proposed that ΔΨm
is maintained by the synergistic activities of the F1-ATPase and
the electrogenic exchange of ADP for ATP mediated by the
AAC (22). Unlike yeast “petite mutants” or mammalian ρ0
cells, dyskinetoplastic trypanosomes are successful in nature,
where they are transmitted mechanically by bloodsucking in-
sects among a vast range of mammals or by coitus in equids
(50). It is striking that in African trypanosomes of the trypa-
nozoon group, the kinetoplast DNA loss has occurred
repeatedly and does not appear to impair cell viability of the
replicative stage in the mammalian bloodstream (48). The loss
of kinetoplast DNA in BSF trypanosomes is most likely facil-
itated by the facts that (i) these cells rely only on a single
mitochondrial-encoded protein, the subunit a of the FoF1–
ATP synthase, (ii) they do not use the FoF1–ATP synthase for
energy production, as glycolysis fulfills their ATP demands,
thanks to the abundant glucose in the mammalian host’s
bloodstream, and (iii) these cells acquire a compensatory
mutation that affects F1–ATPase function (22). We speculate
that the long-term tolerance of reduced levels of FoF1–ATPase,
exemplified by our BSF Tb1 5’ and OSCP RNAi cell lines, can
provide BSF cells with a time frame to gain nuclear muta-
tion(s) that allow ΔΨm generation in the absence of an intact
FoF1–ATPase and consequently facilitate life without kineto-
plast DNA (22). This has major implications, as a number of
trypanocidal compounds, including those that constitute the
currently available treatments for animal African trypanoso-
miasis, target the kinetoplast DNA network (51–53) and,
indeed, the loss of dependence on kinetoplast DNA due to the
compensatory mutations has been related to multidrug resis-
tance in trypanosomes (54–56). Our results further highlight
how the parasite’s unique biology helps this species to cope
with the loss of mitochondrial DNA, an event that is delete-
rious, or even lethal, for the majority of eukaryotes (57).
A striking phenotype exhibited by BSF Tb1 3’ RNAi and
OSCP cDKO trypanosomes is the reduced respiration rate
upon Tb1 and OSCP depletion, respectively, as there is no
direct link between the activities of AOX and the FoF1–
ATPase. Rather, the oxygen consumption rate by AOX is a
measure of glycolysis, which provides BSF trypanosomes with
the majority, if not all, of the cellular ATP (34, 58). We hy-
pothesize that disruption of the FoF1–ATPase complex leads toa lower consumption rate of intracellular ATP. In support of
this argument, we observed a gradual reduction in the cellular
ADP/ATP ratio after suppression of Tb1 or OSCP expression.
A recent study showed that T. brucei AOX can be inhibited by
a transient accumulation of intramitochondrial ATP caused by
inhibition of the FoF1–ATPase hydrolytic activity with oligo-
mycin (35), representing the first report proposing that the
FoF1–ATPase activity can affect the glycolytic flux in BSF
trypanosomes. Similarly, oligomycin treatment inhibits the
rates of oxygen consumption and pyruvate production with a
concomitant dissipation of ΔΨm when glucose is the substrate
(15, 59). This effect that was originally contributed to the in-
hibition of glycolysis before triose phosphate oxidation (60)
can now be linked to the inhibition of the FoF1–ATPase. Ac-
cording to the metabolic control theory (61), the flux control
of a pathway can be exerted not solely by enzymes from the
particular pathway but also by processes outside of it, such as
the ATP-consuming processes. In T. brucei, the glycolytic flux
is controlled mainly by enzymes outside of the pathway, spe-
cifically, by hexose transporters responsible for glucose uptake
into the cell (62). The absence of regulation by components
from the pathway is not restricted to this organism, as it was
reported that overexpression of glycolytic enzymes does not
exert significant control on the pathway in both yeast (63) and
bacteria (64). Interestingly, a study in Escherichia coli
demonstrated that incrementing the cytosolic ATP con-
sumption by expression of free F1-ATPase resulted in a 70%
increase in the glycolytic rate, concluding that enzymes
consuming ATP can affect the glycolytic flux (65). Taken all
together, our results further corroborate the idea that the
levels of FoF1–ATPase activity can affect the respiration rate,
playing an unexplored role in controlling the glycolytic rate in
the BSF stage of the parasite.Experimental procedures
Plasmid construction and generation of cell lines
The generation of the PCF Tb1 RNAi cell line was described
in an earlier study (8). To generate the BSF Tb1 5’ and Tb1 3’
RNAi cell lines, Tb1 (Tb927.10.520) ORF fragments of 460 bp
(between nucleotides 30 and 489) and 636 bp (between nucle-
otides 424 and 1060), respectively, were amplified from the
genome of the wild type (WT) BSF T. brucei strain Lister 427
using primers 1 and 2 for the 5’ RNAi fragment, and primers 3
and 4 for the 3’ RNAi fragment. The resulting 5’ and 3’ RNAi
amplicons were cloned into p2T7-177 vector (66) via BamHI
and XhoI restrictions sites and transfected into the puromycin-
resistant T. brucei SmOxB427 cell line (67) and the neomycin-
and hygromycin-resistant T. b. brucei EATRO 1125 AnTat 1.1
90:13 cell line (68), respectively. For the inducible expression of
Tb1 fused with a C-terminal 3x v5 tag, the Tb1 coding sequence
was PCR-amplified from T. brucei strain Lister 427 genome
using primers 5 and 6. Using theHindIII and BamHI restriction
sites inherent in the primers, the fragment was cloned into the
pT7_v5 vector (69). The construct was linearized with NotI and
transfected into the neomycin-resistant transgenic BSF427
single-marker cell line as described previously (11).J. Biol. Chem. (2021) 296 100357 11
Trypanosoma brucei FoF1–ATP synthaseTo generate the BSF OSCP RNAi cell line, an OSCP
(Tb927.10.8030) ORF fragment of 446 bp (between nucleotides 13
and 458) was amplified from the genome of theWT BSF T. brucei
strain Lister 427 using primers 7 and 8. The resulting ampliconwas
cloned into p2T7-177 vector (66) via BamHI and XhoI restrictions
sites, and the construct was linearizedwithNotI before transfection
into the neomycin-resistant transgenic BSF427 single-marker cell
line as described previously (11). For the generation of the BSF
OSCP cDKO cell line, 5’ and 3’ intergenic region fragments from
OSCP gene were amplified using primers 9 and 10 for the 5’
intergenic region, andprimers11 and12 for the3’ intergenic region.
The resulting 5’ intergenic region amplicon of 452 bp was cloned
into NotI and MluI restriction sites within pLEW13 vector to
generate pLEW13::5’ IR452bp vector. Subsequently, the 3’ intergenic
region amplicon of 414 bp was inserted into pLEW13::5’ IR452bp
vector via XbaI and StuI restriction sites to obtain the OSCP single
KO construct. This construct was linearized using NotI and trans-
fected into theWTBSFT. brucei strain Lister 427 to knock out the
firstOSCPallele.Togenerate theconstruct for theKOof thesecond
OSCP allele, the T7 RNA polymerase and neomycin cassette from
theOSCPsingleKOconstructwas replacedbya cassette containing
a 10% activity T7 promoter, the tetracycline repressor, and the
hygromycin resistance gene from pLEW90 vector. For the gener-
ationof the tetracycline-inducibleOSCPectopic copyconstruct, the
OSCP ORF was amplified from the genome of the WT BSF
T. brucei strain Lister 427 using primers 13 and 14. TheOSCPORF
was cloned into BamHI and XhoI restriction sites within pLEW79
vector, replacing the luciferaseORF. It is important tomention that
the pLEW79 vector was mutagenized for the purpose of this study
to include anXhoI restriction sitedownstream itsHindIII site due to
the existence of a HindIII site within the sequence of the OSCP
ORF. BSFT. bruceiOSCP single KO cells were transfectedwith the
OSCP ectopic copy construct before knocking out the second
OSCP allele. The strategy used for the conditional KO of OSCP in
BSF cells was adapted from the reference (70). The correct inte-
gration of theOSCP single KO construct was verified by PCRusing
the following primer pairs: primers 15 (annealing upstream the 5’
intergenic region of the OSCP gene used as homologous recom-
bination site) and 17 (binding the T7 RNA polymerase sequence);
primers18 (binding theneomycin resistance gene sequence) and16
(annealing downstream the 3’ intergenic region of the OSCP gene
used as homologous recombination site). The correct integration of
the OSCP double KO construct was verified by PCR using the
following primer pairs: primers 15 and 19 (which binds the tetra-
cycline repressor sequence); primers 20 (binding the hygromycin
resistance gene sequence) and 16. The presence of the OSCP
inducible copywas verifiedbyPCRusingprimers21 (which anneals
to the procyclic acidic repetitive protein promoter) and 22
(annealing downstream the aldolase 3’UTR that follows the OSCP
ORF). A schematic representation of the PCR verification is
depicted on Fig. S2. The sequences of all the primers used in this
study are found in Table S1.
T. brucei culture conditions
The PCF Tb1 RNAi cell line was grown at 27 C in the
glucose-rich medium SDM-79 (27) (Invitrogen 07490916N)12 J. Biol. Chem. (2021) 296 100357supplemented with 10% fetal bovine serum (BioSera FB-1090/
500) and 7.5 mg/ml hemin (Sigma H9039) and containing
15 μg/ml G418 (Sigma G8168), 25 μg/ml hygromycin B Gold
(InvivoGen ant-hg-1), and 2.5 μg/ml phleomycin (InvivoGen
ant-ph-2p).
The BSF T. b. brucei Lister 427 strain, EATRO 1125 AnTat
1.1 (68), stable acriflavine-induced dyskinetoplastic T. b. brucei
EATRO 164 (71), and dyskinetoplastic T. b. evansi AnTat 3/3
that lost mitochondrial DNA upon culturing (16) were all
grown at 37 C and 5% CO2 in HMI-11 medium (Invitrogen
07490915N) supplemented with 10% fetal bovine serum. The
BSF 5’ Tb1 RNAi cell line was grown in the presence of pu-
romycin and phleomycin. The BSF 3’ Tb1 RNAi cell line was
grown in the presence G418, hygromycin, puromycin, and
phleomycin. The BSF OSCP RNAi cell line was grown in the
presence of G418 and phleomycin. The BSF OSCP cDKO cell
line was grown in G418, hygromycin, and phleomycin. The
final concentrations of antibiotics in the culture medium were
the following: 0.1 μg/ml puromycin, 2.5 μg/ml G418, 5 μg/ml
hygromycin, and 2.5 μg/ml phleomycin.
The induction of RNAi and ectopically expressed tagged
Tb1 was triggered by the addition of 1 μg/ml of tetracycline
into the medium. BSF OSCP cDKO cells were constantly
grown in the presence of 1 μg/ml of tetracycline to sustain
OSCP expression. The expression of the OSCP ectopic copy
was suppressed by cultivating BSF OSCP cDKO cells in the
absence of tetracycline, preceded by a two-step washing of the
cells with tetracycline-free medium. For all the experiments in
this study, cells were maintained in a mid-late exponential
growth phase, meaning 0.6 × 107 to 1.2 × 107 cells/ml in the
case of PCF cells, and 0.6 × 106 to 1.2 × 106 cells/ml in the case
of BSF cells.
SDS-PAGE and Western blotting
Appropriate volumes of PCF and BSF culture were spun
down at 1400g for 10 min at 4 C, and cell pellets were washed
once with 1× PBS (10-mM phosphate buffer, 130-mM NaCl,
pH 7.3). To prepare whole-cell lysates at a concentration of 1 ×
107 cells in 30 μl, cell pellets were resuspended in 1× PBS
before the addition of 3× Laemmli buffer (150-mM Tris-HCl,
pH 6.8, 300-mM 1,4-dithiothreitol, 6% (w/v) SDS, 30% (w/v)
glycerol, 0.02% (w/v) bromophenol blue). The mixture was
boiled at 97 C for 10 min and stored at −20 C. For Western
blot analysis, a volume of sample corresponding to 3 ×
106 cells per well was separated by SDS-PAGE (Bio-Rad
4568094), blotted onto a polyvinylidene difluoride membrane
(Pierce 88518), and probed with the appropriate monoclonal
(mAb) or polyclonal (pAb) antibody. This was followed by
incubation with a secondary HRP-conjugated anti-rabbit (Bio-
Rad 1721019) or anti-mouse (Bio-Rad 1721011) antibody
(1:2000), which immunoreacts, respectively, with the poly-
clonal or monoclonal primary antibodies. Proteins were visu-
alized using the Clarity Western ECL substrate (Bio-Rad
1705060EM) on a ChemiDoc instrument (Bio-Rad). The
PageRuler prestained protein ladder (Thermo Fisher Scientific
26617) was used to determine the size of the detected bands.
Trypanosoma brucei FoF1–ATP synthaseThe primary antibodies used in this study were the following:
mAb anti-v5 epitope tag (1:2000, Invitrogen), mAb anti-
mitochondrial HSP70 (1:5000; 72 kDa) (72), mAb anti-AOX
(PCF 1:300, BSF 1:1000, kindly provided by Minu Chaudhuri;
33 kDa), pAb anti-mitochondrial RNA-binding protein 1
(1:1000; 23 kDa), pAb anti-enolase (1:1000; 47 kDa) (73),
pAb anti-AAC (1:1000; 34 kDa), and antibodies against FoF1–
ATP synthase subunits β (1:2000; 54 kDa), p18 (1:1000;
18 kDa), Tb1 (1:1000; 47 kDa), Tb2 (1:1000; 43 kDa), and
OSCP (1:1000; 27 kDa). The latter antibodies were produced
in the Zíková lab and are available upon request. The densi-
tometric analysis of the bands was carried out using the
ImageLab software by relating the signal intensity from the
lanes corresponding to RNAi-induced/tetracycline-depleted
cells to that of the lane pertinent to control cells. The per-
centage of downregulation relative to the control sample was
then normalized to the corresponding signal intensity of the
bands from the blots probed with anti-enolase or anti-
mitochondrial HSP70 (loading controls).
Isolation of crude mitochondrial vesicles
Crude mitochondrial vesicles were obtained by hypotonic
lysis as described earlier (11, 72). In summary, cell pellets from
3 × 108 BSF cells were washed once with a buffer I (150-mM
NaCl, 20-mM glucose, 20-mM phosphate buffer, pH 7.9),
resuspended in a buffer II (1-mM Tris-HCl, pH 8.0, 1-mM
EDTA), and homogenized in a Dounce homogenizer. Alter-
natively, cell pellets from 1 × 109 PCF cells were washed in a
buffer III (150-mM NaCl, 100-mM EDTA, 10-mM Tris-HCl,
pH 8.0), resuspended in the buffer II, and homogenized by
passing through a 25G needle. To restore the physiological
isotonic conditions, 60% sucrose was promptly added to the
cell lysate to attain a final concentration of 250 mM. Samples
were spun down at 16,000g for 10 min at 4 C to clear the
soluble cytoplasmic material from the lysates. The organelle-
enriched pellets were resuspended in STM (250-mM
sucrose, 2-mM MgCl2, 20-mM Tris-HCl, pH 8.0) and sup-
plemented with a final concentration of 3-mM MgCl2 and
0.3-mM CaCl2 before incubating with 5 μg/ml DNase I for 1 h
on ice. Then, an equal volume of STE (250-mM sucrose,
2-mM EDTA, 20-mM Tris-HCl, pH 8.0) was added, and the
material was centrifuged as before. Pellets enriched with the
mitochondrial membrane vesicles were flash-frozen in liquid
nitrogen and stored at −80 C until their use.
Native electrophoresis and in-gel staining of FoF1–ATPase
activity
The protocol for high-resolution clear native electropho-
resis was adapted from published studies (74, 75). Briefly,
crude mitochondrial vesicles from 5 × 108 cells were resus-
pended in a mitochondrial lysis buffer (2-mM ε-aminocaproic
acid (ACA), 50-mM imidazole-HCl, 1-mM EDTA, 50-mM
NaCl, pH 7.0) and lysed for 1 h on ice with 4 mg digitonin/
1 mg protein. Samples were centrifuged at 16,000g for 30 min
at 4 C, and the protein concentrations of the cleared lysates
were determined by bicinchoninic acid assay. Samples weremixed with 5× loading dye (0.1% (w/v) Ponceau-S, 50% (w/v)
glycerol) and loaded onto a 3 to 12% native gradient gel. After
electrophoresis (3 h, 100 V, 4 C), the resolved mitochondrial
proteins were transferred onto a nitrocellulose membrane
(overnight, 20 V, 4 C) and probed with selected antibodies
(p18 1:1000 and Tb1 1:1000).
BNE was performed as described in an earlier study (9) with
some modifications. Crude mitochondrial vesicles from 2 ×
108 cells were resuspended in 1 M ACA and solubilized with
either 2% (PCF) or 4% (BSF) dodecylmaltoside (DDM) for 1 h
on ice. Samples were centrifuged at 16,000g for 30 min at 4 C,
and the protein concentrations of the cleared lysates were
estimated using the bicinchoninic acid assay (Pierce 23225).
Samples were mixed with 1.5 μl of the loading dye (500-mM
ACA, 5% (w/v) Coomassie Brilliant Blue G-250) and loaded
onto a 3 to 12% native gradient gel. After the electrophoresis
(3 h, 140 V, 4 C), proteins were blotted onto a polyvinylidene
difluoride membrane (2 h, 100 V, 4 C, stirring) and immu-
nodetected using antibodies against different FoF1–ATP syn-
thase subunits (subunit β 1:2000, p18 1:1000, Tb2 1:500, and
OSCP 1:100). Alternatively, the gel was transferred into the
ATPase reaction buffer (35-mM Tris-HCl, pH 8.0, 270-mM
glycine, 19-mM MgSO4, 0.3% (w/v) Pb(NO3)2, 11-mM ATP)
for overnight incubation under slow agitation (in-gel staining
of FoF1–ATPase activity). Subsequently, the gel was soaked in
30% methanol to stop the reaction. The ATPase activity ap-
pears as a white precipitate.
Sodium carbonate submitochondrial fractionation
Sodium carbonate extraction of mitochondrial membranes
was adapted from an earlier study (76). Mitochondrial vesicles
from 3 × 108 cells were isolated by hypotonic lysis as described
previously. The resulting supernatant from a 25G needle ho-
mogenization step was kept as a cytosolic fraction. The
mitochondrial pellet was further treated with digitonin (80 μg/
ml) for 15 min on ice to disrupt the mitochondrial outer
membrane. The material was then cleared by centrifugation at
12,000g for 20 min at 4 C and the pelleted mitoplasts were
resuspended in 0.1 M Na2CO3 buffer (pH 11.5) before incu-
bation on ice for 30 min. A final ultracentrifugation step at
100,000g for 1 h at 4 C carried out in an SW50Ti rotor of a
Beckman Instrument yielded a supernatant comprised of
proteins from the mitochondrial matrix, including stripped
peripheral membrane proteins, and a pellet containing integral
proteins isolated from the mitochondrial membrane fraction.
Glycerol gradient sedimentation
Hypotonically purified mitochondrial vesicles from 2.5 ×
109 cells were resuspended in glycerol gradient lysis buffer (10-
mM Tris-HCl, pH 7.2, 10-mM MgCl2, 200-mM KCl, 1-mM
1,4-dithiothreitol) and solubilized with 1% Triton X-100 for
30 min on ice. The lysates were cleared by a centrifugation step
(2× 16,000g, 30 min, 4 C), and the protein concentration was
determined by the Bradford assay. Cleared mitochondrial ly-
sates were resolved by ultracentrifugation (Beckman Instru-
ment, SW40 rotor) at 38,000g for 5 h on an 11- ml 10 to 30%J. Biol. Chem. (2021) 296 100357 13
Trypanosoma brucei FoF1–ATP synthaseglycerol gradient, which was poured using the Gradient Station
(Biocomp) according to the manufacturer’s protocol. The
glycerol gradients were then fractionated with the Gradient
Station, and 500 μl fractions were stored at −80 C.
ΔΨm measurement
The ΔΨm of live cells was estimated using the cell-
permeant red-fluorescent dye TMRE (Thermo Fisher
Scientific T669), whose fluorescence intensity is proportionally
dependent on the ΔΨm values. Equal number of cells (3 × 106)
were harvested for each time point and resuspended in the
culture medium containing 60-nM TMRE. The staining of the
cells was carried out for 30 min at the appropriate temperature
for each life stage. Subsequently, cells were spun down at
1400g for 10 min at room temperature, resuspended in 1 ml of
1× PBS (see composition above) and immediately analyzed by
flow cytometry using BD FACSCanto II instrument and its
blue laser (488 nm) with the band pass PE filter (585/15). For
each sample, 10,000 events were collected. Treatment with 20-
μM carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(Sigma C2920) was used as a control for mitochondrial
membrane depolarization. Data were evaluated using BD
FACS Diva (BD Company) software. The TMRE signal cor-
responding to RNAi-induced/tetracycline-depleted cells was
normalized to that of control cells and expressed in percent-
age. The values were plotted and analyzed statistically using
GraphPad Prism 8.0 software.
In situ ΔΨm of permeabilized cells was determined fluo-
rometrically using safranin O dye (Sigma S2255) (77). For each
sample, 2 × 107 cells were harvested and washed once with
ANT buffer (8-mM KCl, 110-mM K-gluconate, 10-mM NaCl,
10-mM free-acid Hepes, 10-mM K2HPO4, 0.015-mM EGTA
potassium salt, 10-mM mannitol, 0.5 mg/ml fatty acid–free
bovine serum albumin, 1.5-mM MgCl2, pH 7.25) (78). The
cell pellet was resuspended in 2 ml of ANT buffer containing
5-μM safranin O and 4-μM digitonin. Fluorescence was
recorded in a Hitachi F-7100 spectrofluorometer (Hitachi
High-Technologies) at a 5-Hz acquisition rate, using 495 nm
and 585 nm excitation and emission wavelengths, respectively.
Substrates (1-mM ATP, PanReac AppliChem A13480025) and
inhibitors (10 μg/ml oligomycin or 1-μM carboxyatractyloside,
Sigma O4876 and Biorbyt orb259156-10, respectively) were
added where indicated. Final addition of the uncoupler SF
6847 (250 nM; Enzo Life Sciences BML-EI215-0050) served as
a control for maximal depolarization. All the experiments were
performed at room temperature and constant stirring.
Mitochondrial O2
,− and cellular ROS measurements
For the measurement of mitochondrial and cellular ROS
molecules, the red mitochondrial O2
,− indicator MitoSOX
(Thermo Fisher Scientific M36008) and H2DCFHDA dye
(Thermo Fisher Scientific) were used, respectively. The stain-
ing procedure followed was essentially the same as for the
determination of ΔΨm in vivo except that TMRE was replaced
by 5-μM MitoSOX or 10-μM H2DCFHDA in the corre-
sponding assay. MitoSOX and H2DCFHDA fluorescence14 J. Biol. Chem. (2021) 296 100357signals were recorded using BD FACSCanto II instrument and
its blue laser (488 nm) with the band pass phycoerythrin (585/
15 nm) and fluorescein isothiocyanate (530/30 nm) filters,
respectively. The fluorescence signal of RNAi-induced/
tetracycline-depleted cells was normalized to that of control
cells and expressed in percentage. The values were plotted and
analyzed statistically using GraphPad Prism 8.0 software.
High-resolution respirometry
The oxygen consumption rate was determined using the
Oroboros Oxygraph-2K (Oroboros Instruments Corp). For
each sample, 2 × 107 cells were harvested and washed once
with Mir05 mitochondrial respiration medium (0.5-mM
EGTA, 3-mM MgCl2, 60-mM lactobionic acid, 20-mM
taurine, 10-mM KH2PO4, 20-mM Hepes, 110-mM sucrose,
1 mg/ml fatty acid–free bovine serum albumin, pH 7.1). The
cell pellet was resuspended in 2.1 ml of Mir05 and transferred
into the respiration chamber at the appropriate growth tem-
perature for each life stage and under constant stirring. In the
experiments carried out with intact PCF cells, 10-mM glyc-
erol-3-phosphate (Sigma, 17766) was added, and complex IV-
and AOX-mediated respirations were inhibited by injection of
1-mM KCN and 250-μM SHAM (Sigma S607), respectively.
For the experiments performed with permeabilized BSF cells,
the addition of 4-μM digitonin (Sigma D141) preceded the
injection of 20-mM glycerol-3-phopshate into the chamber,
and respiratory inhibition was achieved by addition of 250-μM
SHAM. The most stable portion of either the oxygen con-
sumption rate slope (PCF experiments) or the oxygen con-
centration in the chamber slope (BSF experiments) was
determined for each biological replicate after the addition of
substrates and inhibitors. The values were plotted and
analyzed statistically using GraphPad Prism 8.0 software.
ADP/ATP ratio and total cellular ATP levels
Both the ADP/ATP ratio and the total cellular ATP were
estimated using the bioluminescence-based ADP/ATP assay
kit (Sigma MAK135) following the manufacturer’s protocol. In
brief, 1 × 106 cells per sample were harvested and washed once
with PBS-G (1× PBS plus 6-mM glucose). Cells were resus-
pended in 10 μl of 1× PBS-G and transferred into a white flat-
bottom 96-well microtiter plate. Luminescence was recorded
in an Orion II microplate luminometer (Titertek-Berthold).
The ATP levels and calculated ADP/ATP ratios of RNAi-
induced/tetracycline-depleted cells were normalized to those
of control cells and expressed in percentage. The values were
plotted and analyzed statistically using GraphPad Prism 8.0
software.
Resazurin cell-viability assay
BSF cells were inoculated into a transparent flat-bottom 96-
well microtiter plate at a density of 500 trypanosomes in a final
volume of 200 μl of the culture medium per well. The cells
were incubated in the presence of various drug concentrations
(0.98- to 4000-μM carboxyatractyloside and 9.78–5000 ng/ml
oligomycin) for 72 h at 37 C. Wells without the drug served as
Trypanosoma brucei FoF1–ATP synthasethe control for cell viability. Subsequently, 20 μl of a 125 μg/ml
resazurin (Sigma R7017) stock solution was added and fluo-
rescence was measured 24 h later (total drug incubation time
of 96 h) in a Tecan Spark plate reader using 544-nm and
590-nm excitation and emission wavelengths, respectively.
Data were analyzed with GraphPad Prism 8.0 software using a
nonlinear regression and a sigmoidal dose–response analysis.
All the experiments were performed in triplicate.
Modeling of Tb1 structure
The structure of Tb1 was predicted with I-TASSER (34)
using the structure of E. gracilis Tb1 as a template (PDB ID:
6TDU (6)).
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